MARIA RIOS: Open Payments
NPI 1578612396 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 46 payments from 10 companies in 2025. Trend: 2023 $920 · 2024 $480 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $369 |
| Amgen Inc. | 16 | $255 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Abbott Laboratories | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Novo Nordisk Inc | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| SANOFI PASTEUR INC. | 1 | $15 |
Products named: OTEZLA, Kerendia, MOUNJARO, KISUNLA, ZEPBOUND, JARDIANCE, FARXIGA, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
